Quantcast
Last updated on April 23, 2014 at 11:31 EDT

Latest Pregnancy tests Stories

2009-12-03 07:00:00

SAN DIEGO, Dec. 3 /PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq: SQNM), today announced that Dr. Yves Ville has joined the company's Clinical Advisory Board. Dr. Ville is a prominent obstetrician-gynecologist and currently serves as professor and chairman of the department of obstetrics and fetal medicine at Necker-Enfants-Malades Hospital at the Paris Descartes University. (Logo: http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO) "I am delighted that Yves has agreed to join our...

2009-09-14 08:58:12

New article examines the influence of current tests on birth rates, assesses forthcoming tests, and calls for the establishment of medical and educational policies With new prenatal tests for Down syndrome on the horizon promising to be safer, more accurate, and available to women earlier in pregnancy, the medical community must come together and engage in dialogue about the impact of existing and expected tests, argues a new leading article published Online First by Archives of Disease in...

2009-04-30 17:02:00

HOUSTON, April 30 /PRNewswire/ -- As an expectant mother, her first official Mother's Day doesn't have to be next year, after her special delivery arrives. Here are four unique ideas to make this Mother's Day unforgettable for the expectant mother. Errands Service: For pregnant women prescribed bed rest, this can be a vexing time. She knows it is best for her and the baby (or babies) to stay off her feet, but she is still very aware that laundry is piling up and grocery shopping must be...

2009-02-09 07:00:00

MENLO PARK, Calif., Feb. 9 /PRNewswire/ -- Artemis Health Inc., a privately-held company dedicated to the development of non-invasive prenatal diagnostic tests, today announced that Richard Rava, Ph.D., has joined Artemis Health in the newly created position of senior vice president of research and development. "Rich's depth and breadth of research, development and manufacturing experience, together with his proven track record in commercializing genetic analysis tools, makes him...

2009-02-05 03:00:00

MINEOLA, N.Y., Feb. 5 /PRNewswire/ -- Lenetix, Inc. today announced the launch of an Institutional Review Board (IRB)-approved screening study of an improved first and second trimester non-invasive fetal diagnostic test to detect Down syndrome. The Lenetix PloidYX(TM) maternal blood test promises to be the most accurate and comprehensive test yet developed for the detection of fetal aneuploidies, the presence of extra chromosomes, which cause Down syndrome (T-21) and other chromosomal...

2009-01-27 07:00:00

-- New Technology May Allow Development of Accurate Blood Test for Common Genetic Disorders Early in Pregnancy -- MENLO PARK, Calif., Jan. 27 /PRNewswire/ -- Artemis Health Inc., a privately-held company dedicated to the development of non-invasive prenatal diagnostic tests, today announced that it has acquired a co-exclusive worldwide license from Stanford University to develop cell-free fetal DNA prenatal diagnostic tests based on pioneering research from the lab of Stephen Quake, Ph.D.,...

ac1cacf31da89c8aa19b03b682fb613e1
2009-01-06 06:50:00

New research finds that a genetic defect test performed during early pregnancy appears to increase the chances that a baby will be born with an infantile hemangioma, or birthmark. Chorionic villus sampling, or CVS, which can be performed as early as 10 weeks into pregnancy, uses a needle to collect samples of embryonic material that goes on to form the placenta.  It provides cells of fetal origin that can then be examined for chromosomal defects. Dr. Lewis B. Holmes of Massachusetts...

87f801bbe9ae578010ade1b1fbe908d21
2008-11-18 09:45:56

A "chip" or array that can quickly detect disorders such as Down syndrome or other diseases associated with chromosomal abnormalities proved an effective tool in prenatal diagnosis in a series of 300 cases at Baylor College of Medicine, said researchers in a report that appears in the current issue of the journal Prenatal Diagnosis. In the report, a team led by Dr. Arthur Beaudet and Dr. Sau Wai Cheung at BCM, described use of array comparative genomic hybridization to analyze samples taken...

2008-10-28 09:00:07

Sequenom, Inc. (NASDAQ: SQNM) today announced the launch of an independent, prospective, multi-center observational study to document the performance of Sequenom's SEQureDx(TM) Trisomy 21 technology for Down syndrome based upon Sequenom's SEQureDx Technology. The study, RNA-based Noninvasive Aneuploidy (RNA), will be directed by Jacob Canick, Ph.D., Professor of Pathology and Laboratory Medicine, Brown University Medical School, and Glenn Palomaki, Associate Director, Division of Medical...

2b58457012a785b7be98d5d14e5caa7a
2008-10-07 07:00:00

Scientists say a prenatal blood test can determine if an unborn baby has Down's syndrome, without the risk to the fetus from past invasive testing methods, according to U.S. researchers. Stephen Quake led a team of researchers at Stanford University in California to create a way to look for the extra chromosomes that cause Down's and similar birth detects. Babies with Down's syndrome have an extra copy of chromosome 21, causing physical and intellectual impairments. The test also detects...